The user-friendly web interface allows users to use the three models as they wish by varying the parameters included for each model. The results can then be downloaded in a pre-specified format.

All categories of stakeholders can use this web tool. At a first step, decision makers (health authorities and insurers) can use the tool to improve access to new innovative health technologies, including medicines, by enabling a smoother Health Technology Assessment process. However, the tool can be used by a broad range of stakeholders such as patients, doctors, industry or hospitals, who need information about how to employ pricing, effectiveness, cost-effectiveness, in the context of access to new health technologies.

Although patients might not be the main users of this tool, its use can help provide faster access to innovative health technologies and more transparent pricing.

The aim of ASCERTAIN is to accelerate regulatory, evaluation and decision-making procedures by offering several open-access online models for pricing, HTA and reimbursement. The aim of the ASCERTAIN web tool is to contribute to improved patient access through increasing efficiency regarding reimbursement and market entry decision-making trajectories concerning new health technologies by providing central, open-access, and transparent models that would assist in setting reasonable and reimbursable prices.

Furthermore, the ASCERTAIN web tool was developed by involving representatives of all stakeholders groups that are involved in pricing and reimbursement of health technologies. By doing so, many of the current uncertainties in the process of developing new health technologies, from marketing approval to reimbursement, can be mitigated by using this web tool, or at least be made more transparent.